Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients

References

• BernierJDomengeCOzsahinMEuropean Organization for Research and Treatment of Cancer Trial 22931Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancerN Engl J Med2004350191945195215128894
   PubMed Web of Science ®Google Scholar
• BernierJCooperJSPajakTFDefining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501)Head Neck2005271084385016161069
   PubMed Web of Science ®Google Scholar
• FietkauRLautenschlagerCSauerRPostoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: results of the German phase III trial ARO 96-3J Clin Oncol200624557
   Web of Science ®Google Scholar
• BachaudJMCohen-JonathanEAlzieuCDavidJMSerranoEDaly-SchveitzerNCombined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trialInt J Radiat Oncol Biol Phys199636599910048985019
   PubMed Web of Science ®Google Scholar
• CooperJSPajakTFForastiereAAPostoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neckN Engl J Med2004350191937194415128893
   PubMed Web of Science ®Google Scholar
• BeckerAStadlerPLaveyRSSevere anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomasInt J Radiat Oncol Biol Phys200046245946610661354
   PubMed Web of Science ®Google Scholar
• NorsmarkMOvergaardJTumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancerActa Oncol200443439640315303502
   PubMed Web of Science ®Google Scholar
• Marie-EgyptienneDTLohseIHillRPCancer stem cell, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypxiaCancer Lett20133411637223200673
   PubMed Web of Science ®Google Scholar
• ChangJErlerJHypoxia-mediated metastasisAdv Exp Med Biol2014722558124272354
   PubMed Web of Science ®Google Scholar
• GhattassKAssahREl-SabbanMGali-MuhtasibHTargeting hypoxia for sensitization of tumors to radio- and chemotherapyCurr Cancer Drug Targets201313667068523687923
   PubMed Web of Science ®Google Scholar
• KimJHLeeJMRyuKSThe prognostic impact of duration of anemia during chemotherapy in advanced ovarian cancerOncologist20111681154116121705663
   PubMed Web of Science ®Google Scholar
• FerrandinaGDistefanoMSmaniottoDAnemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcomeGynecol Oncol2006103250050516677692
   PubMed Web of Science ®Google Scholar
• ParkSHLeeJLeeSHAnemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancerCancer Chemother Pharmacol2006571919616088407
   PubMed Web of Science ®Google Scholar
• Nguyen-TanPFLeQTQuiveyJMTreatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the university of California, San Francisco (UCSF) and Stanford university hospital (SUH) experienceInt J Radiat Oncol Biol Phys20015051172118011483326
   PubMed Web of Science ®Google Scholar
• DenisFGaraudPBardetEFinal results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinomaJ Clin Oncol2004221697614657228
   PubMed Web of Science ®Google Scholar
• ProsnitzRGYaoBFarrellCLCloughRBrizelDMPretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancerInt J Radiat Oncol Biol Phys20056141087109515752888
   PubMed Web of Science ®Google Scholar
• RadesDStoehrMKazicNLocally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruption during radiotherapyInt J Radiat Oncol Biol Phys20087041108111417905528
   PubMed Web of Science ®Google Scholar
• FortinAWangCSVigneaultEEffect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancerInt J Radiat Oncol Biol Phys200872125526018632214
   PubMed Web of Science ®Google Scholar
• BhideSAAhmedMRengarajanVAnemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcomeInt J Radiat Oncol Biol Phys200973239139818692326
   PubMed Web of Science ®Google Scholar
• HuKHarrisonLBImpact of anemia in patients with head and neck cancer treated with radiation therapyCurr Treat Options Oncol200561314515610713
   PubMedGoogle Scholar
• ReichelOPanzerMWimmerCDuhmkeEKastenbauerESuckfullMPrognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumorsEur Arch Otorhinolaryngol2003260524825312750913
   PubMed Web of Science ®Google Scholar
• ChenTCHsuCWLouPJThe clinical predictive factors for subsequent distant metastasis in patients with locoregionally advanced oral squamous cell carcinomaOral Oncol201349436737323142556
   PubMed Web of Science ®Google Scholar
• LiaoCTLeeLYHsuehCComparative outcomes in oral cavity cancer with resected pT4a and pT4bOral Oncol201349423023623063612
   PubMed Web of Science ®Google Scholar
• ThomasBStedmanMDaviesLGrade as a prognostic factor in oral squamous cell carcinoma: population-based analysis of the dataLaryngoscope2014124368869423945976
   PubMed Web of Science ®Google Scholar
• SuNWLeuYSLeeJCComparison of the efficacy and toxicity of two dose levels of cisplatin/5-fluorouracil as the chemoradiotherapy regimen for the treatment of locally advanced squamous cell carcinoma of the head and neckActa Otolaryngol2011131121333134022017375
   PubMed Web of Science ®Google Scholar
• MaguirePDMeyersonMBNealCRToxic cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the communityInt J Radiat Oncol Biol Phys200458369870414967423
   PubMed Web of Science ®Google Scholar
• RadesDKronemannSMeynersTComparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of head and neckInt J Radiat Oncol Biol Phys20118041037104420638185
   PubMed Web of Science ®Google Scholar
• MorgantiAGMignognaSDeodatoFFeasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and-neck cancerInt J Radiat Oncol Biol Phys20117941073108020472342
   PubMed Web of Science ®Google Scholar
• van de PolSMGDoornaertPAHde BreeRRene LeemansCSlotmanBJLangendijkJAThe significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapyOral Oncol200642213113816146705
   PubMed Web of Science ®Google Scholar
• RutkowskiTSuwinskiRIdasiakAThe prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancerInt J Radiat Oncol Biol Phys20076941018102317716825
   PubMed Web of Science ®Google Scholar
• RadesDFehlauerFWrobleskyJAlbersDSchildSESchimdtRPrognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapyOral Oncol200743653554317005437
   PubMed Web of Science ®Google Scholar
• SchaferUMickeOMullerSBSchullerPWillichNHemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumorsStrahlenther Onkol2003179852753414509951
   PubMed Web of Science ®Google Scholar
• McCloskeySAJaggernauthWRigualNRRadiation treatment interruptions greater than one week and low hemoglobin levels (12g/dL) are predictors of local regional failure after definite concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neckAm J Clin Oncol20093258759119581794
   PubMed Web of Science ®Google Scholar
• HoffCMImportance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapyActa Oncol201251441943222313317
   PubMed Web of Science ®Google Scholar
• KumarPImpact of anemia in patients with head and neck cancerOncologist20005Sup 21318
   Google Scholar
• HenkeMLaszigRRubeCErythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy: randomized, double-blind, placebo-controlled trialLancet20033293921255126014575968
   PubMed Web of Science ®Google Scholar
• MachtayMPajakTFSuntharalingamMRadiation Therapy Oncology GroupRadiotherapy with or without erythropoietin for anemia patients with head and neck cancer: a randomized trial of the radiation therapy oncology group (RTOG 99-03)Int J Radiat Oncol Biol Phys20076941008101717716826
   PubMed Web of Science ®Google Scholar
• ArcasoyMOAminKChouSCHaroonZAVariaMRaleighJAErythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxiaClin Cancer Res2005111202715671524
   PubMed Web of Science ®Google Scholar
• WinterSCShahKACampoLRelation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinomaClin Cancer Res200511217614762016278379
   PubMed Web of Science ®Google Scholar
• HoffCMHansenHSOvergaardMThe importance of hemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – results from he randomized DAHANCA 5 studyRadiother Oncol2011981283320970213
   PubMed Web of Science ®Google Scholar
• HoffCMLassenPEriksenJGDose transfusion improved the outcome for HNSCC patients treated with radiotherapy? – results from the randomized DAHANCA 5 and 7 trialActa Oncol20115071006101421790306
   PubMed Web of Science ®Google Scholar
• AngKKTrottiABrownBWRandomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancerInt J Radiat Oncol Biol Phys200151357157811597795
   PubMed Web of Science ®Google Scholar
• SuwinskiRSowaARutkowskiTWydmanskiJTarnawskiRMaciewskiBTime factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patientsInt J Radiat Oncol Biol Phys200356239941212738315
   PubMed Web of Science ®Google Scholar
• SherDJPosnerMRTishlerRBRelationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324Int J Radiat Oncol Biol Phys2011815e813e81821300455
   PubMed Web of Science ®Google Scholar
• CannonDMGeyeHMHartigGKIncreased local failure risk with prolonged radiation time in head and neck cancer treated with concurrent chemotherapyHead Neck20143681120112523804248
   PubMed Web of Science ®Google Scholar
• RosenthalDILiuLLeeJHImportance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neckHead Neck200224211512611891941
   PubMed Web of Science ®Google Scholar
• MarcuLGBezakEInfluence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancerCell Prolif201245540441222775509
   PubMed Web of Science ®Google Scholar